Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3904090 | 0.88 | DPP4 (0.69) | DPP4CHRM1 | |
| SCHEMBL3904102 | 0.88 | DPP4 (0.69) | DPP4CHRM1 | |
| SCHEMBL3904081 | 0.87 | DPP4 (0.68) | DPP4CHRM1 | |
| SCHEMBL3892155 | 0.84 | DPP4 (0.71) | DPP4CHRM1 | |
| SCHEMBL3893544 | 0.83 | DPP4 (0.68) | DPP4CHRM1 | |
| SCHEMBL3893534 | 0.83 | DPP4 (0.68) | DPP4CHRM1 | |
| SCHEMBL3906086 | 0.83 | DPP4 (0.70) | DPP4CHRM1 | |
| SCHEMBL3894198 | 0.83 | DPP4 (0.70) | DPP4CHRM1 | |
| SCHEMBL3897908 | 0.83 | DPP4 (0.68) | DPP4CHRM1 | |
| SCHEMBL3890790 | 0.83 | DPP4 (0.68) | DPP4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7560450-B2 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO., KG (DE) | 2009-07-14 | — | — | US | disclosed |
| US-20040138215-A1 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138215-A1 | Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions | DPP4, DPP3, DPP7 | DPP4 1/4885CHRM1 1644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.